Dr Shrinath Barathan, M.D.
Dr. Shrinath Barathan, MD is a health care provider primarily located in Los Angeles, CA, with other offices in Beverly Hills, CA and West Hollywood, CA. He has 31 years of experience. His specialties include Internal Medicine, Nephrology. Dr. Barathan has experience treating conditions like Hypotension (Excluding Maternal), Proteinuria and Secondary Renovascular Hypertension among other conditions at varying frequencies.
Professional Experience
| Clinical Chief of Nephrology 2013–Present | Cedars Sinai Medical Center, Los Angeles. |
| Assistant Professor of Medicine 2011–Present. | David Geffen School of Medicine, UCLA. |
| Clinical Instructor 2004-2011. | David Geffen School of Medicine, UCLA. |
| Attending Staff Physician 2003–Present. | Cedars Sinai Medical Center, Los Angeles. |
| Preceptor 2012–Present. | School of Nursing. California State University, Los Angeles. |
| Partner. 2003–Present. | Tower Nephrology Medical Group, Los Angeles. |
| Assistant Medical Director. | 2009–Present. Crescent Heights Dialysis Center. Los Angeles. |
Committees At Cedars Sinai Medical Center
| 2013–Present | Department of Medicine Performance Improvement Committee |
| 2008 – Present | Pharmacy and Therapeutics Commitee |
| 2010 – Present | Joint Dialysis Oversight Committee |
| 2010 – Present | Best Practices for Continuous Renal Replacement Therapy Committee |
| 2010 – Present | Cardiac Surgical ICU Innovation Project |
| 2010 – Present | Vaptan Task Force |
| 2011-Present | Code Sepsis Committee – Clinical Team to device protocols for septic patients |
| 2011-Present | Electronic Medical Record. CS Link Nephrology Task Force |
Education And Training
| College | BS in Chemistry. Presidency College, Madras University, India. 1983-1986. |
| Medical | MD. 1987-1993. National Pirogov Memorial Medical University, Vinnytsya. Ukraine. |
| Residency | Internal Medicine, 1997-2000. MetroHealth Medical Center, The Rammelkamp Center for Education and Research, MetroHealth Medical Center. Case Western Reverse University, Cleveland, Ohio. |
| Fellowship | Nephrology, 2000-2003. University Hospitals, MetroHealth Medical Center, VA Medical Center, Cleveland, Ohio. Case Western Reserve University. |
Awards And Certifications
| 1987 | Fully funded scholarship to medical school sponsored by Governments of India and USSR. |
| 1993 | Certified Teacher of Russian Language. |
| 2000 | Diplomate in Internal Medicine, American Board of Internal Medicine. |
| 2000 | ACLS Provider |
| 2000 | BLS Provider |
| 2003 | Board Certified, Subspecialty Board in Nephrology, American Board of Internal Medicine. |
Licensures
| Medical | California State Medical Board |
Other Services
President. 1986-1987. Foreign Students Association. National Pirogov Memorial Medical University, Vinnytsya. Ukraine.
Languages Spoken
English, Russian, Malayalam and Tamil
Scientific Presentations
Senior Resident Grand Rounds, 2000, “Progression of Chronic Renal Disease”, Metro Health Medical Center, Cleveland, OH
Research Days 2000, “Comparison of mRNA kidney expression profiles generated by Serial Analysis of Gene Expression (SAGE) to identify candidate nephropathy genes in C57BL/6-Os/ + Versus ROP-Os/ + mice”, Rammelkamp Center for Education and Research, MetroHealth Medical Center, Cleveland OH.
Research Days 2002, “The cell guidance molecule neuropilin-2 is under expressed in podocytes of sclerosis-prone ROP-Os/+, but not C57Bl/6-Os/+mice”, Rammelkamp Center for Education and Research, MetroHealth Medical Center, Cleveland, OH.
Journal Club, 2002, “Treatment of Lupus Nephritis”, University Hospital of Cleveland, Cleveland, OH.
Journal Club, 2003. “Major Outcomes in High-Risk Hypertensive Patients Randomized Patients Randomized to ACE Inhibitor or Calcium Channel Blocker vs. Diuretic” The ALLHAT Trial. University Hospitals of Cleveland, Cleveland, OH.
Clinical Study Location
Tower Nephrology Medical Group, 8641 Wilshire ST #485W Los Angeles, CA 90048
Davita Tower Dialysis 8635 West 3rd St Los Angeles CA 90048
Da Vita of Crescent Heights, 8151 Beverly blvd Los Angeles, CA 90048
Original Contributions
Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes. El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M, Sedor JR. BMC Nephrol. 2012 Jul 19;13:61. doi: 10.1186/1471-2369-13-61.
Serial analysis of gene expression. El-Meanawy MA, Barathan S, Hayden PS, Iyengar SK, Schelling JR, Sedor JR. Methods Mol Med. 2003;86:257-74.
Generation of kidney transcriptomes using serial analysis of gene expression. Schelling JR, El-Meanawy MA, Barathan S, Dodig T, Iyengar SK, Sedor JR. Exp Nephrol. 2002;10(2):82-92.
Reviews
M.A. El-Meanawy, J.R. Schelling, S. Barathan, S.K. Iyengar and J.R. Sedor. Serial analysis of gene expression (SAGE). In: Methods in Molecular Medicine: Renal Disease. Guide to Technical Approaches.
M.S. Goligorsky, ed. The Humana Press, Totowa, NJ, in press 2002.
Abstracts
Goddard KA, El-Meanawy A, Schelling JR, Elashi E, Barathan S., Konieczkowski M., Kamat S, Koepke S, Covie A, Sedor JR and Iyengar SK. Comparison of mRNA kidney expression profiles generated by serial analysis of gene expression (SAGE) to identify candidate nephropathy genes in C57BL/6Os/+ versus ROP-Os/+mice. Am J Hum Genet 67:1456T, 2000. El-Meanawy, A., J. Schelling, E. Elashi, S. Barathan, M. Konieczkowski, S. Kamaet, A. Koepke,
K. Goddard, A. Covic, S Iyengar and J. Sedor. Comparison of mRNA kidney expression profiles generated by serial analysis of gene expression to identify candidate nephropathy genes in C57BL/6-Os/+ versus ROP-Os/+mice. J. Am Soc. Nephrol, 11:617A, 2000.
J.R. Schelling, A. El-Meanawy, E. Elashi, S. Barathan, M. Konieczkowski, S. Kamat, A. koepke, K. Goddard, A. Covic, S.I. Iyanar and J.R. sedor. Comparison of mRNA kidney expression profiles generated by serial analysis of gene expression (SAGE) to identify candidate nephropathy genes in C57BL/6-Os/+ versus ROP-Os/+mice. Nephrology, Dialysis and Transplantation 15:A34, 2000.
El-Meanawy, S. Barathen, M. Konieczkoski, E. Elashi A. Covic, T. Dodig, S. Khan, A. Koepke, F. Pozuelo, K. Goddard, S. Iyangar, J.R. Schelling and J.R. Sedor. Gene expression profiles generated by serial analysis of gene expression (SAGE) identify candidate molecular pathways regulating progressive glomerulosclerosis. Nephrology, Dialysis and Transplantation 16:A38,2001.
El-Meanawy, M.A., S. Barathan, T. Dodig, E. Elashi, K. Goddard, S. K. Iyengar, J.R. Schelling and John R. Sedor. Kidney transcriptome profiles generated by serial analysis of gene expression identify candidate molecular pathways regulating progressive glomerulosclerosis. J. Am. Soc. Nephrol. 12:617A, 2001.
Barathan, S., M. Konieczkowski, A. El-Meanawy*, S. Khan, B. Wang, T. Dodig, S.K. Iyengar, J.R. Schelling and J.R. Sedor. Expression analysis demonstrated the cell guidance signal neuropilin 2b (nrp2) is reduced in sclerosis-prone Rop-Os/+ but not sclerosis-resistant C57-Os/+ mouse kidneys. J. Am. Soc. Nephrol. 12:617A, 2001.
P. Hayden, M.A. El-Meanawy, S. Barathan, G. Jarad, M. Srichai, M. Konieczkowski, S. Iyengar, J.R. Schelling, J.R. Sedor. Serial Analysis of Gene expression (SAGE)- Generated Libraried from Kidneys of Sclerosis-Prone and Sclerosis-Resistant Mice Identify aRenal Disease-Associated Replicon. J. Am Soc. Nephrol. 13:118A, 2002.
S. Barathan, S. Iyengar, L. Bruggeman, P. Mundel, M. El-Meanawy, M. Konieczkowski, J. Schelling, J. Sedor. The Cell Guidance Molecule Neuropilin-2 Is Underexpressed in Podocytes of Sclerosis-Prone ROP-Os/+, but Not C57B1/6-Os/+Mice. J. Am Soc. Nephrol.13:124A, 2002.
M.B. Srichai, M. Konieczkowski, S. Barathan, S. Khan, P. Mundel, S. Lee, L. Bruggeman, J.R. Schelling, J.R. Sedor. A Novel WT1 Co-Regulator That Shuttles between Nucleus and Plasma Membrane, J. Am. Soc. Nephrol. 13:16A, 2001